NRGN and Alzheimer disease: Future studies by IP‐MS [as in (Kvartsberg et al., 2019)], aiming at analyzing changes of individual Ng peptides in CSF, may indeed find some peptides showing a large change, indicative of proteolytic events during AD progression.